An experimental treatment for Alzheimer's Disease originally developed 5 years ago by Arcadia Dr. William K. Summers has been recommended to the U.S. Food and Drug Administration. The drug is called THA.
The City Council approved a recommendation to hire Glendale-based Charles Walton Associates to prepare a library building program. The proposal will cost between $50,000 and $55,000 and the new library will cost approximately $7 million.
The City Council approved an application for $9 million in state funds to build a new library. If the state awards the funds and the council accepts them, the city would have to contribute $7 million toward the new library.
Families of 13 Alzheimer's disease patients filed a class action law suit to order the government to approve the drug THA. Dr. William Summers of Arcadia was the first to report that THA was effective against Alzheimer's disease 5 years ago.
The Food and Drug Administration cleared the way Monday for expanded testing of the drug THA, a promising drug to treat Alzheimer's Disease. Arcadia resident Dr. William Summers first reported that THA was beneficial to Alzheimer's patients in 1986 in an article in the New England Journal of Medicine.
Rose Hassing, 27, currently the director of volunteer services for the Pasadena American Red Cross, will become the new senior citizens supervisor for the City of Arcadia as of February 7. She is replacing Betty Harris, who retired in December after 20 years with the city's senior citizens services.